Schonfeld Strategic Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.36 $35,653 - $48,008	35,300 New	35,300 $38,000
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $1.21 Million - $2.02 Million	-184,665 Reduced 40.64%	269,746 $1.85 Million
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $913,914 - $1.23 Million	-115,832 Reduced 20.31%	454,411 $4.71 Million
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $1.12 Million - $2.84 Million	158,005 Added 38.33%	570,243 $4.61 Million
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $173,077 - $221,872	12,078 Added 3.02%	412,238 $6.49 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $471,827 - $657,742	-36,100 Reduced 8.27%	400,160 $6.3 Million
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $370,840 - $623,419	-36,500 Reduced 7.72%	436,260 $6.09 Million
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $172,398 - $317,184	-17,700 Reduced 3.61%	472,760 $8.15 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $275,032 - $414,453	-22,415 Reduced 4.37%	490,460 $7.13 Million
Q3 2021 Nov 16, 2021	BUY	$13.38 - $18.8 $3.46 Million - $4.86 Million	258,531 Added 101.65%	512,875 $9.23 Million
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $1.93 Million - $3.35 Million	-113,048 Reduced 30.77%	254,344 $4.47 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $354,483 - $1.68 Million	60,492 Added 19.71%	367,392 $9.26 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $152,905 - $439,097	57,700 Added 23.15%	306,900 $1.99 Million
Q3 2020 Nov 16, 2020	BUY	$1.5 - $2.71 $79,650 - $143,901	53,100 Added 27.08%	249,200 $1,000
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $180,787 - $300,732	173,834 Added 780.71%	196,100 $318,000
Q1 2020 May 15, 2020	BUY	$0.75 - $2.18 $16,699 - $48,539	22,266 New	22,266 $23,000
Q4 2018 Feb 14, 2019	SELL	$6.3 - $15.4 $409,500 - $1 Million	-65,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $1,438 - $2,089	-100 Reduced 0.15%	65,000 $944,000
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $317,217 - $391,799	19,272 Added 42.05%	65,100 $1.3 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $782,742 - $1.18 Million	45,828 New	45,828 $804,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$41.3 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$13.6 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$9.78 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$8.72 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$7.99 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account